Post-Marketing Surveillance Study of OTEZLA

Study of Efficacy and Safety of Investigational Treatment in Patients With Nail Psoriasis

NCT05072886 ·Status: UNKNOWN ·Phase: PHASE1

Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast

NCT02749370 ·Status: COMPLETED ·Phase: PHASE4

Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis

NCT00090129 ·Status: TERMINATED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

NCT03832738 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy Subjects

NCT02976831 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis

NCT03441789 ·Status: COMPLETED ·Phase: PHASE4

Adherence to Otezla

NCT05601492 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1

Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis

NCT05268016 ·Status: COMPLETED ·Phase: PHASE2

Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis

NCT03310320 ·Status: TERMINATED ·Phase: PHASE1

A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis

NCT02564042 ·Status: COMPLETED ·Phase: PHASE2

Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

NCT03850483 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris

NCT01465282 ·Status: COMPLETED ·Phase: PHASE2

CT 327 in the Treatment of Psoriasis Vulgaris

NCT00995969 ·Status: COMPLETED ·Phase: PHASE2

Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT07290569 ·Status: RECRUITING ·Phase: PHASE2

Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.

NCT00417820 ·Status: COMPLETED ·Phase: PHASE1

CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis

NCT03168256 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test

NCT00236171 ·Status: COMPLETED ·Phase: NA

A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis

NCT02618616 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy

NCT03930186 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

NCT03895372 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-IIb Trial)

NCT03372811 ·Status: COMPLETED ·Phase: PHASE2

Body PSOriasis: Long-term Relapse CONTROL

NCT03402828 ·Status: COMPLETED

Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis

NCT01119339 ·Status: COMPLETED ·Phase: PHASE2

Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis

NCT01230138 ·Status: COMPLETED ·Phase: PHASE2

LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects

NCT00833872 ·Status: COMPLETED ·Phase: PHASE1